Daily Optical Coherence Tomography Examinations after First Antivascular Endothelial Growth Factor Injections: An Interventional Case Series

Purpose. To evaluate daily spectral-domain optical coherence tomography (SD-OCT) changes in naive-treatment patients with diagnosis of exudative age-related macular degeneration (AMD) treated with intravitreous bevacizumab (1.25 mg), during a 30-day follow-up period. Methods. In prospective, interve...

Full description

Saved in:
Bibliographic Details
Main Authors: Eduardo A. Novais, Emmerson Badaró, Flavio E. Hirai, Felipe Abdo Jorge, Paula Leal, Michel Eid Farah, Eduardo B. Rodrigues
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2016/6971831
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849691364664541184
author Eduardo A. Novais
Emmerson Badaró
Flavio E. Hirai
Felipe Abdo Jorge
Paula Leal
Michel Eid Farah
Eduardo B. Rodrigues
author_facet Eduardo A. Novais
Emmerson Badaró
Flavio E. Hirai
Felipe Abdo Jorge
Paula Leal
Michel Eid Farah
Eduardo B. Rodrigues
author_sort Eduardo A. Novais
collection DOAJ
description Purpose. To evaluate daily spectral-domain optical coherence tomography (SD-OCT) changes in naive-treatment patients with diagnosis of exudative age-related macular degeneration (AMD) treated with intravitreous bevacizumab (1.25 mg), during a 30-day follow-up period. Methods. In prospective, interventional study, SD-OCT was performed daily for 30 days after the first intravitreal injection. The baseline, initial-decrease, minimal, and final central retinal thicknesses (CRTs) were assessed. Results. Nine eyes of nine patients with neovascular AMD were enrolled. The mean baseline CRT was 625.3±182.5 μm, and the mean final CRT was 383.4±163.0 μm (mean difference, 206.1±167.6 μm), a difference that reached significance (P=0.006). After the first injection, the initial decrease in the CRT was seen as an average of one day after injection (mean CRT, 503.6±189.10 μm; P=0.0431). The speed of the reduction in the CRT tended to decrease by day 17. The mean CRT was 336.5±105.44 μm and the mean minimal CRT on day 30 was 320.75±96.38 μm. Conclusion. The CRT decreased early after the first injection. We observed a tendency for reductions in the speed with which the CRT decreased by day 17 after the first injection, which may affect retreatment regime.
format Article
id doaj-art-e85be9e7c49b4783b0425c0fc52a92a1
institution DOAJ
issn 2090-004X
2090-0058
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-e85be9e7c49b4783b0425c0fc52a92a12025-08-20T03:21:03ZengWileyJournal of Ophthalmology2090-004X2090-00582016-01-01201610.1155/2016/69718316971831Daily Optical Coherence Tomography Examinations after First Antivascular Endothelial Growth Factor Injections: An Interventional Case SeriesEduardo A. Novais0Emmerson Badaró1Flavio E. Hirai2Felipe Abdo Jorge3Paula Leal4Michel Eid Farah5Eduardo B. Rodrigues6Department of Ophthalmology, Federal University of São Paulo, 04023-062 São Paulo, SP, BrazilDepartment of Ophthalmology, Federal University of São Paulo, 04023-062 São Paulo, SP, BrazilDepartment of Ophthalmology, Federal University of São Paulo, 04023-062 São Paulo, SP, BrazilDepartment of Ophthalmology, Federal University of São Paulo, 04023-062 São Paulo, SP, BrazilDepartment of Ophthalmology, Federal University of São Paulo, 04023-062 São Paulo, SP, BrazilDepartment of Ophthalmology, Federal University of São Paulo, 04023-062 São Paulo, SP, BrazilDepartment of Ophthalmology, Federal University of São Paulo, 04023-062 São Paulo, SP, BrazilPurpose. To evaluate daily spectral-domain optical coherence tomography (SD-OCT) changes in naive-treatment patients with diagnosis of exudative age-related macular degeneration (AMD) treated with intravitreous bevacizumab (1.25 mg), during a 30-day follow-up period. Methods. In prospective, interventional study, SD-OCT was performed daily for 30 days after the first intravitreal injection. The baseline, initial-decrease, minimal, and final central retinal thicknesses (CRTs) were assessed. Results. Nine eyes of nine patients with neovascular AMD were enrolled. The mean baseline CRT was 625.3±182.5 μm, and the mean final CRT was 383.4±163.0 μm (mean difference, 206.1±167.6 μm), a difference that reached significance (P=0.006). After the first injection, the initial decrease in the CRT was seen as an average of one day after injection (mean CRT, 503.6±189.10 μm; P=0.0431). The speed of the reduction in the CRT tended to decrease by day 17. The mean CRT was 336.5±105.44 μm and the mean minimal CRT on day 30 was 320.75±96.38 μm. Conclusion. The CRT decreased early after the first injection. We observed a tendency for reductions in the speed with which the CRT decreased by day 17 after the first injection, which may affect retreatment regime.http://dx.doi.org/10.1155/2016/6971831
spellingShingle Eduardo A. Novais
Emmerson Badaró
Flavio E. Hirai
Felipe Abdo Jorge
Paula Leal
Michel Eid Farah
Eduardo B. Rodrigues
Daily Optical Coherence Tomography Examinations after First Antivascular Endothelial Growth Factor Injections: An Interventional Case Series
Journal of Ophthalmology
title Daily Optical Coherence Tomography Examinations after First Antivascular Endothelial Growth Factor Injections: An Interventional Case Series
title_full Daily Optical Coherence Tomography Examinations after First Antivascular Endothelial Growth Factor Injections: An Interventional Case Series
title_fullStr Daily Optical Coherence Tomography Examinations after First Antivascular Endothelial Growth Factor Injections: An Interventional Case Series
title_full_unstemmed Daily Optical Coherence Tomography Examinations after First Antivascular Endothelial Growth Factor Injections: An Interventional Case Series
title_short Daily Optical Coherence Tomography Examinations after First Antivascular Endothelial Growth Factor Injections: An Interventional Case Series
title_sort daily optical coherence tomography examinations after first antivascular endothelial growth factor injections an interventional case series
url http://dx.doi.org/10.1155/2016/6971831
work_keys_str_mv AT eduardoanovais dailyopticalcoherencetomographyexaminationsafterfirstantivascularendothelialgrowthfactorinjectionsaninterventionalcaseseries
AT emmersonbadaro dailyopticalcoherencetomographyexaminationsafterfirstantivascularendothelialgrowthfactorinjectionsaninterventionalcaseseries
AT flavioehirai dailyopticalcoherencetomographyexaminationsafterfirstantivascularendothelialgrowthfactorinjectionsaninterventionalcaseseries
AT felipeabdojorge dailyopticalcoherencetomographyexaminationsafterfirstantivascularendothelialgrowthfactorinjectionsaninterventionalcaseseries
AT paulaleal dailyopticalcoherencetomographyexaminationsafterfirstantivascularendothelialgrowthfactorinjectionsaninterventionalcaseseries
AT micheleidfarah dailyopticalcoherencetomographyexaminationsafterfirstantivascularendothelialgrowthfactorinjectionsaninterventionalcaseseries
AT eduardobrodrigues dailyopticalcoherencetomographyexaminationsafterfirstantivascularendothelialgrowthfactorinjectionsaninterventionalcaseseries